1. Home
  2. NCLH vs RGEN Comparison

NCLH vs RGEN Comparison

Compare NCLH & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCLH
  • RGEN
  • Stock Information
  • Founded
  • NCLH 1966
  • RGEN 1981
  • Country
  • NCLH United States
  • RGEN United States
  • Employees
  • NCLH N/A
  • RGEN N/A
  • Industry
  • NCLH Marine Transportation
  • RGEN Medical/Dental Instruments
  • Sector
  • NCLH Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • NCLH Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • NCLH 11.5B
  • RGEN 6.5B
  • IPO Year
  • NCLH 2013
  • RGEN N/A
  • Fundamental
  • Price
  • NCLH $26.66
  • RGEN $113.54
  • Analyst Decision
  • NCLH Buy
  • RGEN Buy
  • Analyst Count
  • NCLH 19
  • RGEN 10
  • Target Price
  • NCLH $28.33
  • RGEN $163.78
  • AVG Volume (30 Days)
  • NCLH 16.5M
  • RGEN 700.4K
  • Earning Date
  • NCLH 10-30-2025
  • RGEN 11-11-2025
  • Dividend Yield
  • NCLH N/A
  • RGEN N/A
  • EPS Growth
  • NCLH 61.59
  • RGEN N/A
  • EPS
  • NCLH 1.54
  • RGEN N/A
  • Revenue
  • NCLH $9,560,994,000.00
  • RGEN $673,956,000.00
  • Revenue This Year
  • NCLH $8.20
  • RGEN $16.74
  • Revenue Next Year
  • NCLH $10.43
  • RGEN $13.86
  • P/E Ratio
  • NCLH $17.30
  • RGEN N/A
  • Revenue Growth
  • NCLH 5.22
  • RGEN 8.73
  • 52 Week Low
  • NCLH $14.21
  • RGEN $102.97
  • 52 Week High
  • NCLH $29.29
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • NCLH 62.92
  • RGEN 40.89
  • Support Level
  • NCLH $24.36
  • RGEN $117.18
  • Resistance Level
  • NCLH $26.28
  • RGEN $122.71
  • Average True Range (ATR)
  • NCLH 0.81
  • RGEN 4.36
  • MACD
  • NCLH 0.11
  • RGEN -0.55
  • Stochastic Oscillator
  • NCLH 83.90
  • RGEN 6.59

About NCLH Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 71,000). It operates 34 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 38,400 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: